Blog

Coriell Institute Added New Collection of Rett Syndrome Stem Cells to its Biobank

The Coriell Institute for Medical Research has added a new collection of stem cells to its biobank offerings. The new collection is a result of a collaboration between Coriell and the Rett Syndrome Research Trust (RSRT) and consists of 10 lines of human-induced pluripotent stem cells created from blood donated by individuals with Rett syndrome. Rett syndrome is […]

Biospecimen Bone Infection Registry Finds Higher MRSA Rate in North America

An international, biospecimen registry on Staphylococcus aureus in fixation or arthroplasty showed higher rates of MRSA in North American patients and poorer subjective outcomes among those with MRSA vs. methicillin-sensitive S. aureus. Researchers from the AO trauma Clinical Priority Program (CPP) collected microbiological and immunological data, including bacterial isolates, blood, and sera, from 292 patients with long bone and joint […]

Medicines Discovery Catapult creates a worldwide virtual biobank

Medicines Discovery Catapult (MDC) announced the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators. MDC welcomed Audubon Biosciences, Biomex, Caltag Medsystems and Tissue for Research to its network of patient sample suppliers, building upon its ongoing collaboration with Tissue Solutions. The rapid expansion of the virtual network to over 330 […]

Jens Habermann Appointed Director General of BBMRI-ERIC

The Assembly of Members of the Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC) appointed Professor Jens K. Habermann as the new Director-General. The distinguished scientist, clinician and recognized expert in biobanking, translational cancer research, and human genetics will take office in Graz on September 1st, 2020. He succeeds Erik Steinfelder […]

Biobanking for Glomerular Diseases

Glomerular diseases, a set of debilitating and complex clinical disease entities affecting individuals of all ages, are associated with significant mortality and morbidity, including hospitalization and ESRD. Although there are many advances in understanding novel genetic and environmental factors affecting the pathophysiology of various glomerular diseases, there is an insufficient number of basic and translational […]

Need for the development of the microbiome biobanking infrastructure

The microbiome research field is rapidly evolving, but the required biobanking infrastructure is currently fragmented and not prepared for the biobanking of microbiomes. The rapid advancement of technologies requires an urgent assessment of how biobanks can underpin research by preserving microbiome samples and their functional potential. A team of scientists, led by CABI’s Dr. Matthew […]